메뉴 건너뛰기




Volumn 19, Issue 22, 2012, Pages 3722-3729

Hepatocellular carcinoma: Important biomarkers and their significance in molecular diagnostics and therapy

Author keywords

Hepatocellular carcinoma (HCC); Multi kinase inhibitor

Indexed keywords

2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; BRIVANIB; CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPITHELIAL CELL ADHESION MOLECULE; ERLOTINIB; FAS LIGAND; FOLLISTATIN; GEFITINIB; GLYPICAN 3; GOLGI PROTEIN 73; HERMES ANTIGEN; LINIFANIB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MICROSOMAL AMINOPEPTIDASE; POLO LIKE KINASE; PROTEIN; PROTEIN P18; PROTEIN P300; SCATTER FACTOR; SORAFENIB; SQUAMOUS CELL CARCINOMA ANTIGEN; SUNITINIB; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; Y BOX BINDING PROTEIN 1;

EID: 84865240172     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801661059     Document Type: Review
Times cited : (25)

References (81)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.